Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Tailored eradication therapy based on fecal Helicobacter pylori clarithromycin sensitivities.

Journal of gastroenterology and hepatology - 1 Dec 2008

Kawai Takashi, Yamagishi Tetsuya, Yagi Kenji, Kataoka Mikinori, Kawakami Kohei, Sofuni Atsushi, Itoi Takao, Sakai Yoshihiro, Moriyasu Fuminori, Osaka Yoshiaki, Takagi Yu, Aoki Tatsuya, Rimbara Emiko, Noguchi Norihisa, Sasatsu Masanori

Abstract excerpt

BACKGROUND AND AIM: Helicobacter pylori (H. pylori) eradication rates using the PPI/AC regimen (proton pump inhibitor + amoxicillin + clarithromycin) are declining. We trialed tailoring eradication regimens according to clarithromycin (CAM) susceptibility. METHODS: The subjects were 70 H. pylori positive adults. They were randomly allocated to a tailored group and a control group. In the tailored group, subjects...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amoxicillin
Share to Clarithromycin

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cytochrome P-450 CYP2C19

Share to Helicobacter Infections

Share to Metronidazole

Share to Patient Selection

Share to Proton Pump Inhibitors

Share to Ribotyping

Source

Identifiers

PMID: 19120893
DOI: 10.1111/j.1440-1746.2008.05408.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Tailored eradication therapy based on fecal Helicobacter pylori clarithromycin sensitivities.PMID 19120893Read ↗

Tailored versus Triple plus Bismuth or Concomitant Therapy as Initial Helicobacter pylori Treatment: A Randomized Trial.Semantic proximity Read ↗

Usefulness of detection of clarithromycin-resistant Helicobacter pylori from fecal specimens for young adults treated with eradication therapy.Semantic proximity Read ↗

Efficacy of genotypic susceptibility-guided tailored therapy for Helicobacter pylori infection: A systematic review and single arm meta-analysis.Semantic proximity Read ↗

Eradication of Helicobacter pylori According to 23S Ribosomal RNA Point Mutations Associated With Clarithromycin ResistanceSemantic proximity Read ↗

Current and future insights in H. pylori eradication regimens: the need of tailoring therapy.Semantic proximity Read ↗

Empirical Therapy Versus Tailored Therapy of Helicobacter pylori in Korea: Results of the K-CREATE Study.Semantic proximity Read ↗

Personalized treatment in the eradication therapy for Helicobacter pylori.Semantic proximity Read ↗

Application of Visual Gene Clip-Based Tailored Therapy for the Eradication of Helicobacter pylori.Semantic proximity Read ↗

Efficacy of tailored Helicobacter pylori eradication therapy based on antibiotic susceptibility and CYP2C19 genotype.Semantic proximity Read ↗

Usefulness of Molecular Diagnostic Kits for Detecting Helicobacter pylori Infection in Patients Receiving Proton Pump Inhibitors and Potassium-Competitive Acid Blockers.Semantic proximity Read ↗

Multiple-antibiotic-resistant Helicobacter pylori infection eradicated with a tailor-made quadruple therapy.Semantic proximity Read ↗

Smart Gene™ as an effective non-invasive point-of-care test to detect Helicobacter pylori clarithromycin-resistant mutation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.